Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Portal Vein Tumour Thrombosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT03322280
What this trial is testing

TACE Combined With Iodine-125 Seeds Implantation for HCC

Who this might be right for
Hepatocellular CarcinomaPortal Vein OcclusionTumor Thrombus
Second Affiliated Hospital of Guangzhou Medical University 270
Testing effectiveness (Phase 2)UnknownNCT02452853
What this trial is testing

HR Combined With FOLFOX4 for HCC With PVTT

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 51
Not applicableStudy completedNCT01556282
What this trial is testing

TheraSpheres Treatment for Unresectable Hepatocarcinoma and Portal Vein Thrombosis

Who this might be right for
Liver CancerPortal Vein Thrombosis
Emory University 35
Not applicableStudy completedNCT01177631
What this trial is testing

Proteomic Analysis of Human Hepatocellular Carcinoma

Who this might be right for
Carcinoma, Hepatocellular
Far Eastern Memorial Hospital 5
Post-approval studies (Phase 4)Ended earlyNCT01600196
What this trial is testing

Resection vs. Best Supportive Care for Hepatocellular Carcinoma (HCC) With Portal Venous Thrombus

Who this might be right for
Hepatocellular Carcinoma With Portal Vein Tumor Thrombus
Sun Yat-sen University 126
Not applicableUnknownNCT04631458
What this trial is testing

Outcomes in Patients With Myeloproliferative Neoplasm and Splanchnic Vein Thrombosis

Who this might be right for
Myeloproliferative NeoplasmSplanchnic Vein ThrombosisSplanchnic Venous Thrombosis+1 more
Royal Free Hospital NHS Foundation Trust 40
Testing effectiveness (Phase 2)Study completedNCT04945720
What this trial is testing

Hepatic Artery Infusion Chemotherapy (HAIC) Plus Durvalumab for Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 30
Testing effectiveness (Phase 2)Study completedNCT01850368
What this trial is testing

Stereotactic Ablative Radiotherapy for Hepatocellular Carcinoma With Major Portal Vein Invasion

Who this might be right for
Hepatocellular CarcinomaPortal Vein Tumor Thrombus
Korea Cancer Center Hospital 35
Large-scale testing (Phase 3)Ended earlyNCT04709380
What this trial is testing

Phase III RCT of Radiotherapy Plus Toripalimab Versus Sorafenib in Advanced Hepatocellular Carcinoma With PVTT

Who this might be right for
RadiotherapyToripalimabSorafenib+1 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 36
Post-approval studies (Phase 4)Looking for participantsNCT07132515
What this trial is testing

Efficacy & Safety of Anticoagulants in Cirrhosis ± HCC

Who this might be right for
CirrhosisHCC - Hepatocellular CarcinomaPortal Vein Thrombosis
Mansoura University 100
Testing effectiveness (Phase 2)UnknownNCT04947826
What this trial is testing

Combination Therapy of HAIC and HLX10 and HLX04 in HCC With Major Portal Vein Tumor Thrombosis

Who this might be right for
Hepatocellular Carcinoma With Major Portal Vein Thrombosis
Shanghai Zhongshan Hospital 100
Large-scale testing (Phase 3)UnknownNCT03192644
What this trial is testing

The Impact on Recurrence Risk of Adjuvant Transarterial Chemoinfusion (TAI) Versus Adjuvant Transarterial Chemoembolization (TACE) for Patients With Hepatocellular Carcinoma And Portal Vein Tumor Thrombosis (PVTT) After Hepatectomy : A Random, Controlled, Stage III Clinical Trial.

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 162
Testing effectiveness (Phase 2)UnknownNCT04169399
What this trial is testing

Toripalimab Plus Stereotactic Body Radiotherapy for HCC With PVTT

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 30
Not applicableUnknownNCT03914352
What this trial is testing

A Novel Immunotherapy PD-1 Antiboty to Suppress Recurrence of HCC Combined With PVTT After Hepatic Resection

Who this might be right for
Hepatocellular Carcinoma
Cancer Hospital of Guangxi Medical University 40
Testing effectiveness (Phase 2)Looking for participantsNCT07776080
What this trial is testing

Iparomlimab and Tuvonralimab With Lenvatinib, Radiotherapy, and HAIC for Hepatocellular Carcinoma With Portal Vein Tumor Thrombus

Who this might be right for
HCC - Hepatocellular Carcinoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 35
Large-scale testing (Phase 3)Ended earlyNCT01887717
What this trial is testing

Efficacy Evaluation of TheraSphere to Treat Inoperable Liver Cancer With Blockage of the Portal Vein

Who this might be right for
Hepatocellular Carcinoma
Boston Scientific Corporation 36
Not applicableStudy completedNCT00825669
What this trial is testing

Treatment of Portal Vein Tumor Thrombus After Hepatocellular Carcinoma Resection

Who this might be right for
Hepatocellular Carcinoma
Eastern Hepatobiliary Surgery Hospital 100
Not applicableActive Not RecruitingNCT06248528
What this trial is testing

Comparing the Prognosis of Patients With HCC and PVTT Treated With Surgery Versus Locoregional Therapy.

Who this might be right for
Hepatocellular Carcinoma
Chen Xiaoping 1,076
Post-approval studies (Phase 4)UnknownNCT04127396
What this trial is testing

Lenvatinib Plus TACE Versus Sorafenib Plus TACE for HCC With PVTT

Who this might be right for
Carcinoma, HepatocellularPortal Vein Tumor Thrombus
Beijing Ditan Hospital 72
Large-scale testing (Phase 3)UnknownNCT04025437
What this trial is testing

Neoadjuvant Radiotherapy for HCC Involving Type I PVTT

Who this might be right for
Hepatocellular Carcinoma
Guangxi Medical University 214
Next Page